Re-Connect Application for Smoking Cessation
Launched by ROWAN UNIVERSITY · Jan 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Re-Connect Application for Smoking Cessation trial is designed to help people quit smoking by using a smartphone app. The study will look at how acceptable and effective it is to give access to the app only if participants can show that they have not smoked for a certain period. This means that the app will help track their progress and support their journey to becoming smoke-free.
To be eligible for this study, participants must be at least 18 years old, smoke at least 10 cigarettes a day for the past 2 years, and have a strong desire to quit smoking. They should also be comfortable using a smartphone and able to read and speak English. It's important that participants do not have certain health issues that could complicate their participation, such as severe breathing problems or unmanaged mental health conditions. If you decide to join, you can expect support in your quit-smoking journey, with the app providing guidance and tools to help you succeed.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • individuals who report smoking at least 10 cigarettes per day for at least 2 years, -18 years of age or older
- • do not have any health complications that might interfere with the study or require more intensive treatment (e.g., emphysema, chronic obstructive pulmonary disorder, asthma, lactose intolerance)
- • report a strong desire to quit smoking (8 or higher on a 10-point Likert scale)
- • has prior experience using a smartphone, speak English, and are literate, will be eligible for the study.
- Exclusion Criteria:
- • Individuals with mental health complications that are either un-managed or that have been managed for less than 6-months
About Rowan University
Rowan University is a comprehensive public institution dedicated to advancing knowledge and improving health outcomes through innovative research and education. As a clinical trial sponsor, Rowan University leverages its extensive academic resources and expertise in various medical and health fields to conduct rigorous clinical studies. The university is committed to ethical research practices, fostering collaboration among multidisciplinary teams, and ensuring the safety and well-being of participants. Through its clinical trials, Rowan University aims to contribute significantly to the advancement of medical science and the development of effective treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glassboro, New Jersey, United States
Patients applied
Trial Officials
Bethany Raiff, PhD
Principal Investigator
Rowan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials